Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment

Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment

Abstract Background In the adjuvant setting of cancer treatment, de-escalation strategies have the goal of omitting or minimizing treatment in patients, without compromising outcomes. Historically, eligibility for adjuvant treatment solely relied on the patient’s clinical and tumor’s pathological ch...

Full description

Bibliographic Details
Main Authors: Timothée Olivier, Vinay Prasad
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Medicine
Subjects:
Adjuvant therapy
Oncology
Molecular test
Gene signature
ctDNA
Evidence-based medicine
Online Access:https://doi.org/10.1186/s12916-022-02589-6

Internet

https://doi.org/10.1186/s12916-022-02589-6

Similar Items